NCT SouthWest: Tübingen-Stuttgart/Ulm
The oncology centers of excellence Tübingen-Stuttgart (CCC-TS) and Ulm (CCCU) form the joint site NCT SüdWest. The NCT SüdWest is an internationally leading site with a clinical research focus on molecular therapies and academic drug development, innovative immunotherapies as well as molecular and multiparametric imaging. The SouthWest site stands for the rapid transfer of new research results and academically developed therapeutics and diagnostics into early clinical trials. This ensures that innovations in cancer research benefit patients as quickly as possible.
Main research areas
The research expertise of the NCT SouthWest is based on three pillars in particular: Personalized immunotherapies include the areas of individualized cancer peptide vaccines, innovative antibody therapies and cellular immunotherapies. The second pillar consists of the development of targeted molecular therapies to overcome therapy resistance. Here, the site primarily contributes its expertise to the NCT through the Tübingen Center for Academic Drug Discovery. NCT SüdWest's research expertise is complemented by imaging-based tumor diagnostics. The use of state-of-the-art multimodal imaging techniques at the sites in Tübingen, Stuttgart and Ulm, such as PET/MR scanners or whole-body PET/CT scanners, paired with the latest generation of tracers developed in-house, enables a new form of planning and control of personalized forms of therapy.
Managing Directorate of the NCT SouthWest
Prof. Dr. Sara Brucker
Spokesperson of the Steering Committee for the NCT SouthWest
Managing Director NCT SouthWest
Medical Director Department for Women's Health / Research Institute for Women's Health / University Women's Hospital Tübingen
Prof. Dr. Hartmut Döhner
Spokesperson of the Steering Committee for the NCT SouthWest
Managing Director NCT SouthWest
Department of Internal Medicine III, Center for Internal Medicine, Ulm University Hospital
Prof. Dr. Lars Zender
Spokesperson of the Steering Committee for the NCT SouthWest
Managing Director NCT SouthWest
Medical Director of the Clinic for Medical Oncology & Pneumology, Department of Internal Medicine, Tübingen
Prof. Dr. Matthias Schwab
Managing Director NCT SouthWest
Director of the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology at the Bosch Health Campus
Holder of the Chair of Clinical Pharmacology at the University of Tübingen
Medical Director of the Department of Clinical Pharmacology at the University Hospital of Tübingen
Eva Enzinger
Member of the Managing Directorate of the NCT SouthWest
Head of Administration NCT SouthWest
Dr. Christiane Koch | Marilena Poxleitner |
Dr. Julia Sander |
Head of CTC
Prof. Dr. med. Matthias Schwab
Medical Director Department of Clinical Pharmacology
at the University Hospital Tübingen
Head of the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology
at the Bosch Health Campus, Stuttgart
Apl. Prof. Dr. Ulrich Lauer
Deputy Medical Director Department of Internal Medicine VIII
Head of Early Clinical Trials Unit
University Hospital Tübingen
Prof. Dr. Stephan Stilgenbauer
Medical Director Comprehensive Cancer Center Ulm
Head of Early Clinical Trials Unit University Hospital Ulm
Steven Pohl | Anja Biebl |